ROS EXPLOITATION TO INCREASE EFFICACY OF RAF PATHWAY INHIBITION IN MELANOMA

$577,739FY2019Defense Health AgencyDOD

Cincinnati Univ Of

Investigators

ROS EXPLOITATION TO INCREASE EFFICACY OF RAF PATHWAY INHIBITION IN MELANOMA · GrantIndex